GLYCOLIPOPEPTIDBIOTENSIDE

European patent · EP3440179 · In force

Register entry

Publication number
EP3440179
Application number
EP17719188
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Apr 6, 2017
Published
Feb 13, 2019
Granted
Jun 3, 2020
Protection ends at the latest
Apr 5, 2037
Next annual fee due
Apr 30, 2027
IPC classes
C11D 3/38 (2006.01)
C02F 3/34 (2006.01)
C12R 1/01 (2006.01)
C07H 15/04 (2006.01)
C11D 1/66 (2006.01)
C11D 1/10 (2006.01)
Priority
GB 201605875 06.04.2016
PCT application
PCT/EP2017/058296 06.04.2017
PCT publication
WO2017/174748 12.10.2017
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. May 1, 2026

    Change

    Published in Swissreg on 01.05.2026

  2. May 1, 2025

    Change

    Published in Swissreg on 01.05.2025

  3. May 1, 2024

    Change

    Published in Swissreg on 01.05.2024

  4. May 1, 2023

    Change

    Published in Swissreg on 01.05.2023

  5. Jul 21, 2020

    Agent entered

    Representative
    Dennemeyer AG, Bahnhofstrasse 23, 6300 Zug

    Published in Swissreg on 21.07.2020

  6. Jun 3, 2020

    Granted

    Published in Swissreg on 03.06.2020

Parties

Holder

Croda International Plc

Croda International PLC

Cowick Hall Snaith, Goole, Yorkshire DN14 9AA, GB

Agent

Dennemeyer AG

Bahnhofstrasse 23, 6300 Zug

Inventor

HALTLI, Bradley Arnold

New Haven, Prince Edward Island C0A 1H3, CA

KERR, Russell Greig

Charlottetown, Prince Edward Island C1A 3A9, CA

BERRUÉ, Fabrice

Halifax, Nova Scotia B3H 3T6, CA

MARCHBANK, Douglas Hubert

Stratford, Prince Edward Island C1B 1R6, CA

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.